CrossLife Technologies (United States)
- Research works
- 64 ▼ 98% vs 2013–17
- Citations
- 1.5k 23.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 21% world 28%
Not ranked overall: CrossLife Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does CrossLife Technologies (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 11.8× the share of its output that it takes of world research.
- Molecular BiologySubfield · 30.3 works12×
- Biochemistry, Genetics and Molecular BiologyField · 42.7 works9.6×
- Life SciencesDomain · 43.9 works4.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at CrossLife Technologies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Data Analysis, Normalization, Genomic Instability, Targeted Therapy, Cancer Genomics, Mutational Signatures and Quantitative.
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Gene Therapy
- Biopharmaceutical Production
- Genomics
- Therapeutic Antibodies
- RNA Regulation
- Bioinformatics
- Signal Transduction
- Metastatic Breast Cancer
- RNA methylation
- Self-Assembly
- Glycosylation
- Biosensors
- Genome Engineering
- Cancer
- Quantitative
- Cancer Genomics
- Genomic Instability
- Data Analysis
- Gene Expression
- Normalization
- Targeted Therapy
- Mutational Signatures
- Real-Time PCR
- Nanoparticles
- RNA-Guided
- Machine Learning
- DNA nanotechnology
- Membrane Proteins
- m6A-seq
- Gene Regulation
- Transcriptional Regulation
- Monoclonal Antibody
- Monoclonal Antibodies
- Epigenetic Regulation
- Therapy
- Embryonic Stem Cells
- Bacterial Physiology
- DNA Methylation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Expression9▲ 23×9 topics
- Data Analysis6▲ 28×2 topics
- Normalization6▲ 127×2 topics
- Genomic Instability6▲ 70×2 topics
- Targeted Therapy6▲ 41×4 topics
- Cancer Genomics5▲ 145×1 topic
- Mutational Signatures5▲ 145×1 topic
- Quantitative5▲ 62×1 topic
- Real-Time PCR5▲ 176×1 topic
- Cancer4▲ 4.4×9 topics
- Nanoparticles4▲ 4.5×3 topics
- Genome Engineering4▲ 95×1 topic
- RNA-Guided4▲ 95×1 topic
- Biosensors3▲ 8.0×3 topics
- Machine Learning3▲ 2.1×5 topics
- Glycosylation3▲ 20×2 topics
- DNA nanotechnology2▲ 36×1 topic
- Self-Assembly2▲ 9.3×1 topic
- Membrane Proteins2▲ 19×2 topics
- RNA methylation2▲ 45×1 topic
- m6A-seq2▲ 45×1 topic
- Metastatic Breast Cancer2▲ 53×2 topics
- Gene Regulation2▲ 21×4 topics
- Signal Transduction2▲ 13×4 topics
- Transcriptional Regulation2▲ 13×5 topics
- Bioinformatics2▲ 26×3 topics
- Monoclonal Antibody2▲ 44×2 topics
- RNA Regulation2▲ 28×2 topics
- Monoclonal Antibodies2▲ 21×2 topics
- Therapeutic Antibodies2▲ 23×2 topics
- Epigenetic Regulation2▲ 13×4 topics
- Genomics2▲ 8.2×3 topics
- Therapy2▲ 13×2 topics
- Biopharmaceutical Production2▲ 33×2 topics
- Embryonic Stem Cells2▲ 34×2 topics
- Gene Therapy2▲ 9.3×3 topics
- Bacterial Physiology2▲ 47×1 topic
- Chemotherapy-Induced Peripheral Neuropathy2▲ 46×1 topic
- DNA Methylation2▲ 20×2 topics
- Taxanes2▲ 46×1 topic
Which research topics does CrossLife Technologies (United States) publish most on?
By volume in 2022–2025: Bluetooth and Wireless Communication Technologies, IoT-based Smart Home Systems, Context-Aware Activity Recognition Systems and RNA Research and Splicing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bluetooth and Wireless Communication Technologies Computer Networks and Communications 0 works
- 2 IoT-based Smart Home Systems Electrical and Electronic Engineering 0 works
- 3 Context-Aware Activity Recognition Systems Computer Vision and Pattern Recognition 0 works
- 4 RNA Research and Splicing Molecular Biology 0 works
- 5 RNA regulation and disease Molecular Biology 0 works
- 6 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
- 7 RNA Interference and Gene Delivery Molecular Biology 0 works
- 8 Alzheimer's disease research and treatments Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CrossLife Technologies (United States)'s research output changed?
Output in 2018–2022 was 98% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Carlsbad
- Ionis Pharmaceuticals (United States)
- Jones Institute
- Gemological Institute of America
- Viasat (United States)
- Flometrics (United States)
- Neuroscience Education Institute
- Lineage Cell Therapeutics (United States)
- Structural Analytics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.